YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease

Abstract
No abstract available
Funding Information
  • National Institutes of Health (NIH) (P50 AG05681, P01 AG03991, P01 AG026276, P50 AG005136, U01 AG16976, P30 NS057105, T32 NS007205, P41 RR000954)
  • Charles and Joanne Knight Alzheimer Research Initiative
  • Department of Veterans Affairs
  • W.M. Keck Foundation
  • National Institutes of Health/National Institute on Aging (R01AG031278, K23-AG031861, P01 AG019724, P50 AG023501)
  • University Of California, San Francisco Alzheimer's Disease Research Centers (P50 AG023501)
  • CurePSP
  • Association for Frontotemporal Dementias
  • National Center for Research Resources (UL1 RR024992)
  • Eli Lilly
  • Pfizer
  • AstraZeneca
  • American Neurological Association meeting Baltimore, Praque